These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 9418320)

  • 1. [BRCA1 and BRCA2--breast cancer susceptibility genes].
    Dagan E; Gershoni-Baruch R
    Harefuah; 1997 Nov; 133(10):455-7. PubMed ID: 9418320
    [No Abstract]   [Full Text] [Related]  

  • 2. [Is hereditary predisposition to breast cancer linked to BRCA1 a disease of response to genotoxic lesions?].
    Feunteun J
    C R Seances Soc Biol Fil; 1998; 192(2):235-40. PubMed ID: 9759367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.
    Machácková E; Foretová L; Navrátilová M; Valík D; Claes K; Messiaen L
    Cas Lek Cesk; 2000 Oct; 139(20):635-7. PubMed ID: 11192759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary breast cancer.
    Robson ME; Boyd J; Borgen PI; Cody HS
    Curr Probl Surg; 2001 Jun; 38(6):387-480. PubMed ID: 11375625
    [No Abstract]   [Full Text] [Related]  

  • 5. BRCA1. A new marker in the management of patients with breast cancer?
    Offit K
    Cancer; 1996 Feb; 77(4):599-601. PubMed ID: 8616748
    [No Abstract]   [Full Text] [Related]  

  • 6. Lessons learned from BRCA1 and BRCA2.
    Zheng L; Li S; Boyer TG; Lee WH
    Oncogene; 2000 Dec; 19(53):6159-75. PubMed ID: 11156530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer.
    Steinmann D; Bremer M; Rades D; Skawran B; Siebrands C; Karstens JH; Dörk T
    Br J Cancer; 2001 Sep; 85(6):850-8. PubMed ID: 11556836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Brca1 and Brca2 proteins and tumor pathogenesis.
    Ingvarsson S
    Anticancer Res; 1999; 19(4B):2853-61. PubMed ID: 10652564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pregnancy and risk of early breast cancer in patients sith BRCA1 and BRCA2 mutations].
    Ost E; Illiger HJ
    Strahlenther Onkol; 2000 Jul; 176(7):335-6. PubMed ID: 10963002
    [No Abstract]   [Full Text] [Related]  

  • 10. Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study.
    Hopper JL; Southey MC; Dite GS; Jolley DJ; Giles GG; McCredie MR; Easton DF; Venter DJ
    Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):741-7. PubMed ID: 10498392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double heterozygosity for mutations in the BRCA1 and BRCA2 genes in a breast cancer patient.
    Tsongalis GJ; Linfert DR; Johnson RC; Ackroyd R; Berman MM; Ricci A
    Arch Pathol Lab Med; 1998 Jun; 122(6):548-50. PubMed ID: 9625424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inherited predisposition to breast cancer.
    Ponder BA
    Biochem Soc Symp; 1998; 63():223-30. PubMed ID: 9513726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer susceptibility testing: realities in the post-genomic era.
    Friend SH
    Nat Genet; 1996 May; 13(1):16-7. PubMed ID: 8673095
    [No Abstract]   [Full Text] [Related]  

  • 14. Are local recurrences after breast conserving therapy more frequent in patients with BRCA1/BRCA2 mutations?
    Kurtz JM
    Strahlenther Onkol; 2000 Sep; 176(9):433-4. PubMed ID: 11050918
    [No Abstract]   [Full Text] [Related]  

  • 15. [From gene to disease; from BRCA1 OR BRCA2 to breast cancer].
    Van den Ouweland AM
    Ned Tijdschr Geneeskd; 2001 Jun; 145(25):1228. PubMed ID: 11447881
    [No Abstract]   [Full Text] [Related]  

  • 16. [Breast cancer genetics. BRCA1 and BRCA2: the main genes for disease predisposition].
    Ruiz-Flores P; Calderón-Garcidueñas AL; Barrera-Saldaña HA
    Rev Invest Clin; 2001; 53(1):46-64. PubMed ID: 11332051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRCA1, BRCA2 and their possible function in DNA damage response.
    Kote-Jarai Z; Eeles RA
    Br J Cancer; 1999 Dec; 81(7):1099-102. PubMed ID: 10584867
    [No Abstract]   [Full Text] [Related]  

  • 18. Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study.
    Armes JE; Trute L; White D; Southey MC; Hammet F; Tesoriero A; Hutchins AM; Dite GS; McCredie MR; Giles GG; Hopper JL; Venter DJ
    Cancer Res; 1999 Apr; 59(8):2011-7. PubMed ID: 10213514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are BRCA1- and BRCA2-associated breast cancers different?
    Offit K
    J Clin Oncol; 2000 Nov; 18(21 Suppl):104S-6S. PubMed ID: 11060336
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of ten novel and 13 recurring BRCA1 and BRCA2 germline mutations in Italian breast and/or ovarian carcinoma patients. Mutations in brief no. 178. Online.
    De Benedetti VM; Radice P; Pasini B; Stagi L; Pensotti V; Mondini P; Manoukian S; Conti A; Spatti G; Rilke F; Pierotti MA
    Hum Mutat; 1998; 12(3):215. PubMed ID: 10660329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.